All information furnished to APRA pursuant to this chapter shall remain confidential and may be disclosed only to medical personnel for purposes of diagnosis and treatment; except, that with the prior written consent of the client, the information may be disclosed for the purposes of and in accordance with Chapter 2B of this title [§ 7-241 et seq.].
(July 18, 2000, D.C. Law 13-146, § 7, 47 DCR 4350; Dec. 4, 2010, D.C. Law 18-273, § 208, 57 DCR 7171.)
D.C. Law 18-273 substituted “and treatment; except, that with the prior written consent of the client, the information may be disclosed for the purposes of and in accordance with Chapter 2B of this chapter” for “and treatment”.
For temporary (90 day) amendment of section, see § 208 of Data-Sharing and Information Coordination Emergency Amendment Act of 2010 (D.C. Act 18-530, August 6, 2010, 57 DCR 8099).
For temporary (90 day) amendment of section, see § 208 of Data-Sharing and Information Coordination Congressional Review Emergency Amendment Act of 2010 (D.C. Act 18-582, October 20, 2010, 57 DCR 10118).
Structure District of Columbia Code
Title 7 - Human Health Care and Safety
Chapter 30 - Choice in Drug Treatment
§ 7–3001. Legislative findings
§ 7–3003. Establishment of the Drug Treatment Choice Program; purpose
§ 7–3003.01. Establishment of the Access to Recovery Voucher program
§ 7–3004. Establishment of the Addiction Recovery Fund
§ 7–3005. Administration of the Drug Treatment Choice Program and Addiction Recovery Fund
§ 7–3005.01. Certification and participation by treatment providers
§ 7–3006. Confidential records
§ 7–3007. Residency and insurance requirements
§ 7–3009. Certification of treatment providers
§ 7–3010. Quality assurance for treatment providers
§ 7–3012. Infrastructure development plan
§ 7–3014. Choice in Drug Treatment Advisory Commission. [Repealed]